Supracompetitive pricing

• 1. Introduction

  ›

  Supracompetitive pricing names a specific economic condition: prices set above what a genuinely competitive market would allow. Most people have felt the sting of it without knowing the word. A drug with no rival. A company with a patent no one can touch. A local business ground into dust by a deep-pocketed national chain, only for prices to rise once the dust settles.

  The concept sits at an uncomfortable intersection of law, strategy, and ethics. Sometimes supracompetitive pricing reflects a legitimate reward for risk and innovation. Sometimes it is the final act of a carefully orchestrated destruction of competitors. The difficult truth, as economists and regulators have found, is that the line between the two is not always obvious.

  Two researchers, Weismann in 2006 and Baumol in 2003, shaped much of how the academic world frames the two defining stages of this strategy. Their frameworks will be central to understanding how a company can legally charge prices that seem, on their face, unjustifiable. And the debate their work feeds into has yet to produce a settled answer: when, if ever, should governments step in?

• 2. Legal Advantage and Patents

  ›

  A drug company that discovers and successfully manufactures a treatment for a disease occupies a singular position in the market. At that moment, with no rivals and no immediate prospect of any, it can charge prices far above what competition would force it to accept.

  Two separate legal structures protect that position. The first is the regulatory hurdle for drug approval, which creates a substantial barrier that slows any competitor from entering the market even if they wanted to. The second is intellectual property: a patent on the new formulation bars rivals outright unless they can negotiate a license from the patent holder.

  These protections are not accidental. They exist partly to reward the investment and risk that brought the drug into existence. But they also mean that supracompetitive pricing in this context carries an implicit expiration date. Once the patent expires, the legal wall comes down and competition becomes possible again. The pricing power that seemed permanent is, in a strict legal sense, always temporary.

• 3. Predatory Pricing as a Path

  ›

  Predatory pricing runs the process in reverse. Rather than arriving at a dominant position through invention, a company uses deliberately low prices as a weapon. Those prices fall below some measure of economic cost, a threshold researchers call incremental cost, and the goal is explicit: drive competing companies out of the market.

  Weismann's 2006 framework identifies this as the predation phase, the first of two distinct stages. The company accepts real losses during this period. The logic is that once rivals exit, the company can move into the post-predation phase and raise prices to supracompetitive levels, recovering what it lost and then generating profits well beyond what competition would have permitted.

  Baumol, writing in 2003, drew two sharp conclusions from this structure. Supracompetitive prices in the post-predation phase serve to secure monopolistic market position and recover predation-phase losses. And they carry no legitimate business justification beyond that recovery. Those two characteristics, as Baumol framed them, are what separate supracompetitive pricing from ordinary high pricing in a healthy market.

• 4. The Case Against Regulation

  ›

  Regulators and economists have not reached consensus on whether governments should pursue companies that charge supracompetitive prices. Several arguments run against intervention, and they are not trivial.

  The first argument is that supracompetitive prices are self-correcting. High prices attract new entrants who can undercut the dominant firm. The threat of those entrants alone gives dominant companies a reason to keep prices down, at least in markets where barriers to entry are not severe.

  The second argument concerns investment. Temporary high prices exist in dynamic markets precisely because firms need a reward for taking risks. If regulators cap those rewards, the incentive to invest shrinks. A less risky environment means lower returns, and lower returns mean fewer bets on uncertain innovations.

  The third argument is practical: it is genuinely difficult to determine when a price is too high. Dominant companies charge more than marginal cost almost by definition. Baumol's 2003 criteria offer two tests: whether the price threatens the survival of an efficient competitor, and whether it has a legitimate business justification. But applying those tests requires information that regulators do not always have.

  A fourth argument holds that even when authorities identify supracompetitive pricing and fine the offending company, fines are periodic and do not represent a permanent remedy. The pricing problem can resume once the enforcement attention moves on.

• 5. When Predation Becomes Rational

  ›

  The traditional predatory pricing model is widely considered irrational, because the losses in the predation phase may never be recovered if new entrants simply return after the predator raises prices. But researchers have identified conditions under which the strategy becomes rational rather than self-defeating.

  A predatory company operating across multiple markets with multiple products and services gains a reputation effect. Potential entrants in any one market watch what happens in others. If the company has a history of aggressive predation, rivals may choose not to enter even when they could compete successfully, because the reputational signal is credible.

  Information asymmetry is a second condition. If potential entrants and existing competitors do not recognize the signs of a predatory strategy, they cannot respond to it effectively. The predator benefits precisely from that opacity.

  A third condition is the presence of entry barriers that are significant enough to prevent self-correction. In small economies especially, Nair and Mondliwa argued in 2015 that the market's self-correcting ability is limited, which is why they proposed that different countries should establish measures appropriate to their own market conditions.

  Antitrust law, as Gundlach noted in 1995, faces a growing challenge in distinguishing competitive strategies that raise consumer welfare from those that reduce it. Predatory strategy complicates that task considerably, because the predation phase can look, from the outside, like aggressive competition rather than market manipulation.

• 6. Brand Power as a Quieter Route

  ›

  Not every path to supracompetitive pricing runs through predatory pricing or patent law. A company with a trusted brand name and a substantial marketing budget can achieve market dominance through demand creation rather than destruction.

  The mechanism is subtler. A large company floods a market with advertising and promotion, driving consumers toward its product and away from a local competitor's offering. The local competitor does not necessarily get driven out through below-cost pricing; it simply loses customers faster than it can retain them.

  The source describes this as operating, at least in the short term, as a competitive advantage that overwhelms the local rival. Once dominance is established, the dynamic shifts. The dominant company's brand and marketing scale become their own form of barrier to entry, because a new challenger would need comparable resources to compete for the same consumer attention.

  Predatory strategy can also combine with non-predatory strategies in this mold, ones focused not on driving down costs to the consumer but on raising the costs of rivals' products and services. Price predation, in this framing, is one tool in a larger kit that includes raising rivals' costs, expanding brand reach, and exploiting information advantages.